Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether gabapentin enacarbil is effective in the treatment of problems with alcohol.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborators
NCT07223983 · Alcohol Use Disorder, Weight Loss, and more
NCT06770556 · Alcohol Use Disorder, Alcohol Dependence, and more
NCT07027839 · Alcohol Use Disorder
NCT06552741 · Substance Use Disorder, Alcohol Use Disorder
NCT07279558 · Alcohol Use Disorder
University of California Los Angeles
Los Angeles, California
Friends Research Institute
San Francisco, California
University of Miami, Miller School of Medicine
Miami, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions